Pre-clinical unimolecular GLP-1R/GcgR dual-agonists In 2009, research towards unifying GcgR and GLP-1R co-agonism properties into a single non-conjugated unimolecular peptide took its first steps
The conversation spans three main areas: drugs for geroprotection (including GLP-1 agonists, SGLT2 inhibitors, methylene blue, and telomere-lengthening supplements), the use of low-dose aspirin for cardiovascular disease prevention, and strategies to improve muscle mass through optimal protein intake and follistatin gene therapy
Protein-rich foods like chicken or fish typically maintain their appeal, while ultra-processed sweets and salty snacks more commonly taste different
Pr J.-B
21(7): 7525 Gross CJ, Henderson LM, Savaiano DA
Kevin Levrone Gold L-Carnitine 3000 (500 )